BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16450899)

  • 1. Cytologic evaluation of prognostic markers in breast carcinoma.
    Jayaram G; Elsayed EM
    Acta Cytol; 2005; 49(6):605-10. PubMed ID: 16450899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic markers in histologic and cytologic specimens of breast cancer.
    Klorin G; Keren R
    Anal Quant Cytol Histol; 2003 Oct; 25(5):297-302. PubMed ID: 14603729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of immunocytochemistry in fine needle aspiration cytology diagnosis of mammary lesions of breast].
    Di F; Wong NL
    Zhonghua Bing Li Xue Za Zhi; 2006 Dec; 35(12):738-43. PubMed ID: 17374259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of grading and hormone receptor immunostaining on fine needle aspirates in carcinoma breast.
    Handa U; Kumar A; Kundu R; Dalal U; Mohan H
    J Cytol; 2015; 32(1):1-5. PubMed ID: 25948935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ER, PR, and Her2 immunocytochemistry on cell-transferred cytologic smears of primary and metastatic breast carcinomas: a comparison study with formalin-fixed cell blocks and surgical biopsies.
    Ferguson J; Chamberlain P; Cramer HM; Wu HH
    Diagn Cytopathol; 2013 Jul; 41(7):575-81. PubMed ID: 22807465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of estrogen receptors by immunocytochemistry on fine-needle aspiration biopsy specimens from breast tumors.
    Weintraub J; Weintraub D; Redard M; Vassilakos P
    Cancer; 1987 Sep; 60(6):1163-72. PubMed ID: 3304609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine needle aspirate cell blocks are reliable for detection of hormone receptors and HER-2 by immunohistochemistry in breast carcinoma.
    Bueno Angela SP; Viero RM; Soares CT
    Cytopathology; 2013 Feb; 24(1):26-32. PubMed ID: 22220518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate Receptor Alpha Immunohistochemistry in Cytology Specimens of Metastatic Breast Carcinoma.
    Sheikh UN; Cohen C; Siddiqui MT
    Acta Cytol; 2015; 59(4):298-304. PubMed ID: 26413911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multinational study of oestrogen and progesterone receptor immunocytochemistry on breast carcinoma fine needle aspirates.
    Marinšek ZP; Nolde N; Kardum-Skelin I; Nizzoli R; Onal B; Rezanko T; Tani E; Ostović KT; Vielh P; Schmitt F; Kocjan G
    Cytopathology; 2013 Feb; 24(1):7-20. PubMed ID: 23082931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Estrogen and Progesterone Receptors and Her-2 Expression with Grading in the Fine-needle Aspirates of Patients with Breast Carcinoma.
    Toi PC; Neelaiah S; Dharanipragada K; Surendra K
    J Cytol; 2018; 35(4):223-228. PubMed ID: 30498294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The validity of immunocytochemical expression of cyclin D1 in fine needle aspiration cytology of breast carcinoma.
    Ezzat N; Hafez N
    J Egypt Natl Canc Inst; 2012 Sep; 24(3):145-50. PubMed ID: 22929921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and grading of non-Hodgkin's lymphomas on fine needle aspiration cytology.
    Mathur S; Dawar R; Verma K
    Indian J Pathol Microbiol; 2007 Jan; 50(1):46-50. PubMed ID: 17474258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
    Vohra P; Buelow B; Chen YY; Serrano M; Vohra MS; Berry A; Ljung BM
    Cancer Cytopathol; 2016 Nov; 124(11):828-835. PubMed ID: 27315045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical evaluation of estrogen receptor on archival Papanicolaou-stained fine-needle aspirate smears.
    Krishnamurthy S; Dimashkieh H; Patel S; Sneige N
    Diagn Cytopathol; 2003 Dec; 29(6):309-14. PubMed ID: 14648786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis in breast cancer.
    Nijhawan R; Hemachandran M; Joshi K
    Acta Cytol; 2003; 47(2):193-6. PubMed ID: 12685188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of fine needle aspirates processed by ThinPrep® for the assessment of axillary lymph node status in patients with invasive carcinoma of the breast.
    Jing X; Wey E; Michael CW
    Cytopathology; 2013 Dec; 24(6):372-6. PubMed ID: 23020285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of immunocytochemical and biochemical assays for estrogen receptor in fine needle aspirates and histologic sections from breast carcinomas.
    Katz RL; Patel S; Sneige N; Fritsche HA; Hortobagyi GN; Ames FC; Brooks T; Ordonez NG
    Breast Cancer Res Treat; 1990 May; 15(3):191-203. PubMed ID: 1695528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma.
    Gong Y; Symmans WF; Krishnamurthy S; Patel S; Sneige N
    Cancer; 2004 Feb; 102(1):34-40. PubMed ID: 14968416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
    Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
    Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.